📈 நேரலை சந்தை கண்காணிப்பு

NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.

நேரலை இன்று 763 பகுப்பாய்வு செய்யப்பட்டது
பின்தொடர்Telegram
763
இன்று
169,464
இதுவரை பகுப்பாய்வு செய்யப்பட்டவை
50,094
நேர்மறை
8,647
எதிர்மறை
100,887
நடுநிலை
9,768
கண்காணி
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
அழி
1,000+ அறிவிப்புகள் பொருந்தும் தாக்கம் 5+ Symbol: M
நடுநிலை தாக்கம் 6/10 நிதி முடிவுகள்

POLYMED Q2 FY27 Consolidated Revenue Up 30.8% YoY to ₹580.5 Cr, PAT at ₹95.1 Cr

Poly Medicure reported Q2 FY27 consolidated revenue from operations of ₹580.53 Cr, up 30.8% YoY from ₹443.88 Cr in Q2 FY26. Consolidated profit after tax grew 3.6% YoY to ₹95.13 Cr compared to ₹91.80 Cr in Q2 FY26, with PAT margin contracting due to higher raw material and other operational expenses. Basic EPS for the quarter stood at ₹9.38 compared to ₹9.06 a year ago. Additionally, the board classified wholly owned subsidiary Poly Medicure B.V., Netherlands, as a material subsidiary as its net worth surpassed 10% of consolidated net worth.

நேர்மறை தாக்கம் 6/10 டிவிடெண்ட்

Emami Declares ₹5/Share Interim Dividend (500%), Approves Q2 Results & Appoints CS

Emami Limited's Board approved its Q2 FY27 financial results and declared a 1st Interim Dividend of ₹5 per equity share (500% on face value of ₹1) on 42.92 crore equity shares, amounting to an outflow of ~₹214.6 crore. The record date is set for November 13, 2026, with payment on or before December 4, 2026. The company also announced the appointment of Shri Debendra Banthiya as Company Secretary and Compliance Officer effective November 5, 2026. Additionally, the filing noted the successful completion of a ₹281.24 crore share buyback in October 2026 and highlighted auditors' qualified conclusion regarding unreviewed results of certain subsidiaries representing ₹83.57 crore in revenue.

நடுநிலை தாக்கம் 6/10 நிதி முடிவுகள்

Q2 FY27 Net Profit Falls 30.6% YoY to ₹33.34 Cr Despite 42% Revenue Growth to ₹1,191.61 Cr

BEML reported consolidated revenue from operations of ₹1,191.61 Cr for Q2 FY27, up 42.0% YoY from ₹839.09 Cr in Q2 FY26. However, consolidated profit for the period dropped 30.6% YoY to ₹33.34 Cr compared to ₹48.03 Cr in the year-ago quarter, impacted by higher input and operating costs. Sequentially, the company turned around from a net loss of ₹27.01 Cr in Q1 FY27. Diluted EPS for the quarter came in at ₹4.00, down from ₹5.77 in Q2 FY26.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Emami Q2FY27 Revenue Up 36% to ₹1,088 Cr; Declares ₹5 Dividend

Emami reported consolidated revenue from operations of ₹1,088 crore for Q2FY27, up 36% YoY (24% like-to-like), supported by a 49% growth in its domestic business. Operating EBITDA increased 25% YoY to ₹222 crore, though Profit After Tax declined 2.7% to ₹144.4 crore due to higher effective tax rates following the phase-out of fiscal benefits. The Board declared a first interim dividend of ₹5 per share (500% payout totaling ₹214.6 crore) and completed an open-market share buyback worth ₹281.24 crore. Capital returned to shareholders via buyback and interim dividend amounts to ₹495.8 crore, representing ~2.9% of its ₹16,875 crore market capitalization.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

M&M Q2 FY27 Conso PAT Jumps 25% YoY to ₹4,588 Cr; Auto PAT Up 55%

Mahindra & Mahindra reported a 25% YoY increase in consolidated revenue to ₹57,553 crore and a 25% YoY jump in consolidated PAT to ₹4,588 crore for Q2 FY27. Growth was heavily driven by the Auto segment, where consolidated PAT surged 55% YoY to ₹2,388 crore despite raw material cost inflation, while Farm segment PAT dipped 9% YoY to ₹1,053 crore. Standalone revenue grew 26% YoY to ₹44,282 crore with PAT at ₹5,102 crore (up 13% YoY). The company confirmed its automotive capacity expansion path, targeting 82k units per month operational capacity by F27 exit.

📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்

நேர்மறைஎதிர்மறைநடுநிலைகவனம்
எதிர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Fermenta H1FY27 PAT Drops 52% YoY to ₹18.9 Cr, Revenue Down 7% to ₹261.9 Cr

Fermenta Biotech reported a 7% YoY decline in consolidated revenue to ₹261.9 crore for H1FY27, while EBITDA fell 34% YoY to ₹45.6 crore and PAT dropped 52% YoY to ₹18.9 crore. The downturn was primarily driven by the Vitamin D3 Animal Nutrition segment, where sales dropped 52% YoY to ₹22.1 crore due to lower volumes and a 35% decline in realizations. For Q2FY27, revenue was flat at ₹135.8 crore (+0.1% YoY, +8% QoQ) and PAT fell 48% YoY to ₹9.4 crore. Positively, the Human Nutrition segment rose to approximately two-thirds of revenue, and India's revenue contribution expanded to 51% from 40% a year earlier.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Q2 FY27 Total Income Up 45% YoY to ₹538 Cr; PAT Surges 80% to ₹79 Cr

Shilpa Medicare released its Q2 & 1H FY27 earnings presentation, posting its highest-ever quarterly total income of ₹538 crore, up 45% YoY and 15% QoQ. Consolidated EBITDA reached ₹151 crore (up 37% YoY) with an operating margin of 28%, while Q2 PAT surged 80% YoY to ₹79 crore. For 1H FY27, total income surpassed ₹1,000 crore for the first time, reaching ₹1,007 crore (+44% YoY) and PAT reached ₹180 crore (+98% YoY). Performance was supported by API sales reaching ₹254 crore (accounting for 47% of revenue) and an expanded partnership with Orion Corporation for Nivolumab biosimilar in Europe.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Q2FY27 PAT Rises 32.8% YoY to ₹29.5 Cr; Revenue at Record ₹384.7 Cr

M&B Engineering reported its highest-ever quarterly performance in Q2FY27, with sales and services growing 25.4% YoY to ₹384.67 crore. Net profit for the quarter rose 32.8% YoY to ₹29.49 crore, driven by robust order execution across Phenix and Proflex divisions. Total order backlog stood at ₹1,109 crore (up 19.2% YoY), providing strong visibility against TTM revenue of ₹1,313 crore. The company also expanded its Sanand brownfield capacity (Phase-I), taking total PEB capacity to ~124,000 MTPA.

நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Ameya Precision H1 FY27 Net Profit Rises 19.8% YoY to ₹3.45 Cr; Revenue at ₹20.76 Cr

Ameya Precision Engineers reported its un-audited results for the half-year ended September 30, 2026. Revenue from operations reached ₹20.76 Cr, up 2.6% YoY from ₹20.23 Cr in the corresponding period of the previous year. Net profit increased by 19.8% YoY to ₹3.45 Cr compared to ₹2.88 Cr in H1 FY26, driven by lower raw material consumption. Half-yearly EPS expanded to ₹4.60 from ₹3.84, with operating cash flows strengthening significantly to ₹5.53 Cr.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Moneyview Q2 FY27 PAT Jumps 169% YoY to ₹201 Cr; Managed AUM Up 28% to ₹23,892 Cr

Moneyview Limited released its Q2 FY27 investor presentation, reporting a 169.1% YoY (15.6% QoQ) jump in Profit After Tax to ₹201 crore. Total income grew 42.4% YoY to ₹1,146 crore, supported by loan disbursals of ₹7,701 crore (up 41.3% YoY). The company's Managed AUM reached ₹23,892 crore as of September 30, 2026, while Return on Equity stood strong at 27.9%. Asset quality remained stable with GNPA at 2.42% and collection efficiency at 98.64%.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

M&B Engineering Q2 Revenue Up 25.4% to ₹385 Cr; Order Book at ₹1,109 Cr

M&B Engineering published its Q2/H1 FY27 investor presentation, reporting consolidated quarterly revenue growth of 25.4% YoY to ₹385 Cr and net profit up 32.8% YoY to ₹29.5 Cr. The company's orders on hand reached ₹1,109 Cr (up 19% YoY), representing ~84% of TTM revenue. Phase I brownfield expansion at Sanand commenced commercial operations, adding 20,000 MTPA to bring total PEB capacity to ~124,000 MTPA. Management reiterated targets of delivering >25% revenue growth in FY27 and maintaining a >20% CAGR over the next 3-4 years.

நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Campus Activewear Q2FY27 PAT up 21.3% YoY to ₹24 Cr; Revenue rises 16.9% to ₹452 Cr

Campus Activewear reported Q2FY27 revenue of ₹452 Cr, marking a 16.9% YoY increase driven by a 10.2% growth in sales volumes to 63.4 lakh pairs and a 6.1% improvement in Average Selling Price (ASP) to ₹713. EBITDA grew 12.5% YoY to ₹62 Cr, although EBITDA margin contracted slightly by 50 bps to 13.5%. Net profit (PAT) increased by 21.3% YoY to ₹24 Cr, with PAT margin expanding 20 bps to 5.3%. For H1FY27, revenue reached ₹837 Cr (up 14.7% YoY) and PAT stood at ₹50 Cr (up 19.4% YoY), supported by ~29% YoY growth in Women's and Kids' segments.

நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

HMVL Reports Q2 FY27 Consolidated PAT Up 63% YoY to ₹56 Cr; Total Revenue at ₹248 Cr

Hindustan Media Ventures Limited (HMVL) released its Q2 FY27 investor presentation, reporting consolidated operating revenue of ₹197 crore, up 12% YoY from ₹176 crore. Total revenue grew 22% YoY to ₹248 crore, aided by a 90% jump in other income to ₹52 crore. Operating EBITDA rose 65% YoY to ₹74 crore with EBITDA margins expanding to 30% from 22%. Net profit (PAT before exceptional items) surged 63% YoY to ₹56 crore compared to ₹34 crore in Q2 FY26.

நடுநிலை தாக்கம் 6/10 நிதி முடிவுகள்

Moneyview Reports Q2 FY27 Results; Confirms Rs 750 Cr Fresh IPO Proceeds Unutilized

Moneyview Limited reported its financial results for the quarter and half year ended September 30, 2026, following its listing on October 1, 2026. During the quarter, the company completed an IPO raising Rs 10,916.80 million, which included a fresh issue of Rs 7,500.00 million (Rs 750 crore) and an offer for sale of Rs 3,416.80 million. The company reported zero deviation in fund utilization, with the entire fresh issue proceeds of Rs 750 crore remaining unutilized as of September 30, 2026. In addition, its two key operating subsidiaries generated Rs 4,937.78 million in quarterly revenue and Rs 363.25 million in net profit.

நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

HT Media Q2FY27 PAT Jumps 102% YoY to ₹39 Cr; Revenue Up 5% to ₹502 Cr

HT Media reported a 5% YoY increase in consolidated total revenue for Q2FY27 to ₹502 crore, driven by modest growth in the Print segment. EBITDA rose 26% YoY to ₹88 crore, expanding margins to 17% from 15% in Q2FY26. PAT (before exceptional items and JV share) more than doubled to ₹39 crore (+102% YoY). Both the Radio and Digital segments turned EBITDA-positive despite experiencing deliberate revenue contractions from network rationalisation and operational resets.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

Fermenta Biotech Q2 Standalone PAT at ₹13.95 Cr; Revenue at ₹116.94 Cr

Fermenta Biotech reported standalone revenue from operations of ₹116.94 Cr for the quarter ended September 30, 2026, up 9.2% YoY compared to ₹107.12 Cr in Q2 FY26. Standalone profit after tax (PAT) came in at ₹13.95 Cr, registering a decline of 5.2% YoY from ₹14.72 Cr and down 6.9% QoQ from ₹14.99 Cr. Basic EPS for the quarter was ₹4.86 compared to ₹5.05 in the year-ago period. Additionally, the company recognized its 'Environment' business as a separate reportable segment under Ind AS 108.

நடுநிலை தாக்கம் 6/10 நிதி முடிவுகள்

Campus Activewear Q2 FY27 Net Profit Rises to ₹24.14 Cr; Revenue at ₹328.10 Cr

Campus Activewear reported its Q2 FY27 (quarter ended September 30, 2026) standalone financial results with Revenue from Operations reaching ₹328.10 Cr, down 14.8% QoQ from ₹385.20 Cr in June 2026. Net profit for the period came in at ₹24.14 Cr compared to ₹26.14 Cr in the preceding quarter, with Basic EPS at ₹0.79. For the first half (H1 FY27), the company generated ₹713.30 Cr in revenue and ₹50.28 Cr in net profit. However, operating cash flows for H1 FY27 turned negative at -₹74.29 Cr primarily due to a working capital inventory build-up of ₹169.75 Cr.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

HT Media Reports H1 FY27 Standalone Pre-Tax Loss of ₹26.17 Cr vs ₹75.90 Cr YoY

HT Media has approved its unaudited standalone and consolidated financial results for Q2 and H1 ended September 30, 2026. On a standalone basis, the company reported a pre-tax loss of ₹26.17 Cr for H1 FY27, narrowing from a loss of ₹75.90 Cr in the corresponding period of the previous year. Operating cash outflows improved to ₹15.90 Cr compared to ₹20.66 Cr in H1 FY26. Standalone cash and cash equivalents stood at ₹13.20 Cr at the end of September 2026.

நேர்மறை தாக்கம் 6/10 விரிவாக்கம்

Moneyboxx October 2026 disbursements cross ₹50 Cr, more than doubling from August

Moneyboxx Finance reported that monthly loan disbursements crossed ₹50 crore in October 2026 (provisional, unaudited), more than doubling from ₹24.5 crore in August 2026 and ₹32.4 crore in September 2026. This acceleration follows ₹144 crore in debt funding raised in September 2026 across banks, NBFCs, and capital markets. Additionally, the company surpassed the ₹1,000 crore total-asset milestone as of September 30, 2026, transitioning into the Middle Layer NBFC category. The run rate of over ₹50 crore/month represents substantial growth compared to its TTM revenue base of ₹225 crore.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Amagi Reports Q2 FY27 Revenue of ₹476 Cr (+27% YoY); PAT Surges to ₹75 Cr

Amagi Media Labs reported record quarterly revenue of ₹476 Cr for Q2 FY27, up 27% YoY (+33% ex-base and +21% CC ex-base). Adjusted EBITDA expanded 114% YoY to ₹89 Cr with margins expanding 7.6 percentage points to 18.7%. Net profit (PAT) increased significantly to ₹75 Cr (up from ₹3 Cr in Q2 FY26), driven by strong operating leverage and expansion in monetized ad impressions (+65% YoY to 16.0 Bn). Cash reserves stood at ₹1,774 Cr as of September 30, 2026, with an adjusted operating cash flow conversion of 67%.

⚠️ இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்